OTS193320 |
| Catalog No.GC69636 |
OTS193320 is an imidazopyridine compound, a SUV39H2 methyltransferase activity inhibitor. OTS193320 reduces the global histone H3 lysine 9 trimethylation level in breast cancer cells and induces apoptosis cell death. Compared to single-agent OTS193320 or DOX, the combination of OTS193320 with Doxorubicin (DOX; A) can lead to a decrease in γ-H2AX levels and cancer cell viability.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2093401-33-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for OTS193320
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for OTS193320
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *